Publications
-
Potential disease modifying therapies for Huntington’s disease, lessons learned and future opportunities Lancet Neurology
- A biological classification of Huntington’s disease: the Integrated Staging System. Lancet Neurology, 21 (7), 632-644 DOI: 10.1016/S1474-4422(22)00120-X
- “On Chorea”: 150 Years of the Beginning of Hope. Mov Disord DOI: 10.1002/mds.29121
- Huntington’s disease clinical trials corner: April 2022. Journal of Huntington's Disease, 1-14 DOI: 10.3233/JHD-229002
- CAG Somatic Instability in a Huntington Disease Expansion Carrier Presenting with a Progressive Supranuclear Palsy-like Phenotype Movement Disorders DOI: 10.1002/mds.29035
- Polyglutamine diseases Current Opinion in Neurobiology, 72, 39-47 DOI: 10.1016/j.conb.2021.07.001
- Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease NeuroImage: Clinical, 33 DOI: 10.1016/j.nicl.2021.102927
- A MDS Evidence-Based Review on Treatments for Huntington’s Disease Movement Disorders DOI: 10.1002/mds.28855
- Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington’s disease Brain DOI: 10.1093/brain/awab367
- Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease Neurology Genetics, 7 (5), e617- DOI: 10.1212/nxg.0000000000000617